PT  - JOURNAL ARTICLE
AU  - Ofei-Dodoo, Samuel
AU  - Kellerman, Rick
AU  - Russell, Taylor
TI  - Family Physicians' Perception of the New mRNA COVID-19 Vaccines
AID  - 10.3122/jabfm.2021.05.210052
DP  - 2021 Sep 01
TA  - The Journal of the American Board of Family
                Medicine
PG  - 898--906
VI  - 34
IP  - 5
4099  - http://www.jabfm.org/content/34/5/898.short
4100  - http://www.jabfm.org/content/34/5/898.full
SO  - J Am Board Fam Med2021 Sep 01; 34
AB  - Introduction: This study was conducted to assess family physicians' perception of the US Food and Drug Administration-approved mRNA Coronavirus disease 2019 (COVID-19) vaccines, their plans to be vaccinated with an approved mRNA COVID-19 vaccine, and their support for vaccination of patients and family members.Methods: The authors conducted a cross-sectional survey of 307 practicing family physicians, full-time faculty physicians, and resident physicians in Kansas from December 14, 2020, to December 31, 2020. The study participants completed an anonymous, 20-item survey assessing family physicians' concerns about exposure to COVID-19 and their perceptions of the mRNA COVID-19 vaccines to control SARS-CoV-2. A mixed-method approach was used to collect, analyze, and interpret the data.Results: There was a 51.1% response rate. The proportion of family physicians who reported their intentions to be vaccinated for COVID-19 was significantly higher than those who were hesitant to receive the mRNA vaccines (90.6% vs 9.4%; χ2 [1, n = 307] = 201.9.1; P < .0001). Among those who were willing to be vaccinated with an approved mRNA COVID-19 vaccine, the main reasons were to prevent COVID-19 infection; protect self, family, and community; contribute to herd immunity; inspire confidence that the vaccines are safe and end the pandemic and bring life back to normal.Conclusion: Our findings suggest a significantly positive association between a physician's concerns and their willingness to be vaccinated with an approved mRNA COVID-19 vaccine. With the authorization of 2 new mRNA COVID-19 vaccines, future studies should investigate the number of physicians in our study who received the vaccine.